The eighth annual Sloan BioInnovations Conference, taking place on March 4 beginning at 8:30 a.m. in the Boston Marriott Cambridge, brings together thought leaders from industry and academia to discuss important topics applicable across the health-care industries.
Steve Rusckowski, CEO of Philips Healthcare, and Peter Hecht, CEO of Ironwood Pharmaceuticals, will deliver keynote speeches in addition to panel discussions about the challenges of regulatory uncertainty and R&D productivity as well as the opportunities of next generation technologies and emerging markets. Panelists come from top companies across pharma, biotech, medical devices and support services including Pfizer, Genentech, Merck and Genzyme, and innovative emerging firms such as SmartCell and AMAG Pharma.
This year's BioInnovations conference promises to be an insightful discussion on the topics at the center of health care. For full details on panel speakers and to register, visit http://web.mit.edu/sloanhcc/bioinnovations/2011/index.html
Steve Rusckowski, CEO of Philips Healthcare, and Peter Hecht, CEO of Ironwood Pharmaceuticals, will deliver keynote speeches in addition to panel discussions about the challenges of regulatory uncertainty and R&D productivity as well as the opportunities of next generation technologies and emerging markets. Panelists come from top companies across pharma, biotech, medical devices and support services including Pfizer, Genentech, Merck and Genzyme, and innovative emerging firms such as SmartCell and AMAG Pharma.
This year's BioInnovations conference promises to be an insightful discussion on the topics at the center of health care. For full details on panel speakers and to register, visit http://web.mit.edu/sloanhcc/bioinnovations/2011/index.html
